Table 3.
Clinical variables | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | ||
Age at diagnosis | < 55 | Reference | – | – | Reference | – | – |
≥ 55 | 1.699 | 1.325–2.180 | < 0.001 | 1.314 | 1.011–1.707 | 0.041 | |
Gender | Male | Reference | – | – | Reference | – | – |
Female | 0.626 | 0.482–0.814 | < 0.001 | 0.699 | 0.528–0.925 | 0.012 | |
KPS | ≤ 80 | Reference | – | – | Reference | – | – |
> 80 | 0.741 | 0.573–0.958 | 0.022 | 0.874 | 0.670–1.141 | 0.322 | |
Hemisphere | Right | Reference | – | – | – | – | – |
Left | 0.826 | 0.641–1.064 | 0.139 | – | – | – | |
Midline or bilateral | 1.478 | 0.848–2.575 | 0.168 | – | – | – | |
Frontal lobe | Reference | – | – | – | – | – | |
Temporal lobe | 1.314 | 0.935–1.847 | 0.115 | – | – | – | |
Location | Parietal lobe | 0.893 | 0.553–1.443 | 0.645 | – | – | – |
Occipital lobe | 0.923 | 0.426–2.002 | 0.84 | – | – | – | |
Insular lobe | 0.929 | 0.466–1.850 | 0.834 | – | – | – | |
Other regions | 1.632 | 1.198–2.222 | 0.002 | – | – | – | |
Preoperative seizures | No | Reference | – | – | – | – | – |
Yes | 1.231 | 0.868–1.747 | 0.244 | – | – | – | |
Adjuvant therapy | Yes | Reference | – | – | Reference | – | – |
No or undone | 2.059 | 1.533–2.764 | < 0.001 | 2.151 | 1.587–2.916 | < 0.001 | |
Ki67 | < 30% | Reference | – | – | Reference | – | – |
≥30% | 1.261 | 0.983–1.618 | 0.068 | 1.316 | 1.019–1.699 | 0.036 | |
IDH-1 | Mutant | Reference | – | – | Reference | – | – |
Wildtype | 2.867 | 1.917–4.288 | < 0.001 | 2.384 | 1.560–3.643 | < 0.001 | |
SIRI | Low | Reference | – | – | Reference | – | – |
High | 1.843 | 1.431-2.373 | < 0.001 | 1.646 | 1.253–2.163 | < 0.001 | |
NLR | Low | Reference | – | – | Reference | – | – |
High | 1.67 | 1.228-2.270 | 0.001 | 1.392 | 1.013–1.912 | 0.041 |
Significant findings are expressed in bold and italic
Abbreviations: HR hazard ratio, CI confidence interval, KPS Karnofsky performance status, IDH-1 isocitrate dehydrogenase-1, SIRI systemic inflammation response index, NLR neutrophil to lymphocyte ratio, PSM propensity score matching